Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research
RADNOR, PA – May 10, 2024 – Certara, Inc., a global leader in model-informed drug development (MIDD), today announced a new distributor agreement with Cloudscientific. The agreement brings Certara’s leading discovery informatics platform, D360, and Certara’s secure and flexible GPT offering, Certara.AI, to China‘s growing research and development community.
The D360 scientific informatics platform delivers self-service access to data and integrated scientific intelligence resulting in timelier insights for smarter and faster decisions. It is used by more than 6,500 scientists, including five of the top ten biopharmaceutical companies, to advance discovery research for small molecule and biological candidates.
Certara.AI deploys life science-specific GPTs across drug development from early discovery to clinical trials to regulatory submission.
As the pharmaceutical industry races to develop new and effective drugs and treatments, China has emerged as an R&D hub. China’s expenditure reached 2.4% of its GDP in 2020 with 24 drugs approved in the first half of 2023.
This partnership will enable Cloudscientific to provide researchers with the advanced tools and insights they need to accelerate their drug discovery and development efforts.
“Our partnership with Cloudscientific provides greater access to Certara software solutions in China enabling researchers to turn scientific hypotheses into candidate compounds more efficiently,” said Mohan Ponnudurai, Sr Dir Global Partner Alliance at Certara Software.
“Cloudscientific is committed to providing our customers with the best tools and services to support their research,” said Jack Lin, CEO of Cloudscientific. “Certara advances our offering and helps broaden our scientific portfolio enabling our clients to bring new medicines to patients faster”.
Learn more about how you can reduce time, save money, and improve the drug discovery process with Certara.AI at www.certara.com/software/certara-ai-platform.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.